Premium
How doctors think – and treat with botulinum toxin
Author(s) -
Schroeder A Sebastian,
Koerte Inga,
Berweck Steffen,
ErtlWagner Birgit,
Heinen Florian
Publication year - 2010
Publication title -
developmental medicine and child neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.658
H-Index - 143
eISSN - 1469-8749
pISSN - 0012-1622
DOI - 10.1111/j.1469-8749.2010.03692.x
Subject(s) - botulinum toxin , cerebral palsy , spastic , medicine , spastic cerebral palsy , clinical practice , psychology , physical medicine and rehabilitation , family medicine , surgery
Here we add a note about botulinum toxin type A (BoNT-A), a substance used worldwide in applications ranging from (child) neurology to aesthetics, contributing to significantly improved medical care in one field and generating big business in the other. BoNT-A injections are performed thousands of times every day worldwide. Based on the evidence accumulated in over 10 000 publications (PubMed search under ‘botulinum toxin’) there is general consensus that the clinical effect of BoNT-A lasts for about 3–6 months. Therefore, in keeping with clinical